New Cu(II), Pd(II) and Pt(II) complexes, (Cu(L)(H
2
O)
2
(OAc)) (
1
), (Cu(HL)(H
2
O)
2
(SO
4
)) (
2
), (Cu(L)(H
2
O)
2
(NO
3
)) (
3
), (Cu(L)(H
2
O)
2
(ClO
4
)) (
4
), (Cu(L)
2
(H
2
O)
2
) (
5
), (Pd(L)(OAc))H
2
O (
6
), and (Pt(L)
2
) (
7
) were synthesized from 8-ethyl-2-hydroxytricyclo(7.3.1.0
2,7
)tridecan-13-one thiosemicarbazone (
HL
). The ligand and its metal complexes were characterized by IR,
1
H-NMR,
13
C-NMR, UV-Vis, FAB, EPR, mass spectroscopy, elemental and thermal analysis, magnetic susceptibility measurements and molar electric conductivity. The free ligand and the metal complexes have been tested for their antimicrobial activity against
E. coli
,
S. enteritidis
,
S. aureus
,
E. faecalis, C. albicans
and cytotoxicity against the NCI-H1573 lung adenocarcinoma, SKBR-3 human breast, MCF-7 human breast, A375 human melanoma and HL-60 human promyelocytic leukemia cell lines. Copper complex
2
exhibited the best antiproliferative activities against MCF-7 human breast cancer cells. A significant inhibition of malignant HL-60 cell growth was observed for copper complex
2
, palladium complex
6
and platinum complex
7
, with IC
50
values of 1.6 µM, 6.5 µM and 6.4 µM, respectively.